NASDAQ
Biotest AG (BTTAY) has a free cash flow growth of -760.23% as of Friday, May 29, 2026. This represents a 751.34% decrease compared to its 12-month average of 116.72%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.